Skip to content

Gargle Medication Highlights Problematic “Flea Market” Websites in Japan

Although there is still no product proven to cure or prevent COVID-19, misinformation abounds, both in the US and abroad. In Japan, the governor of Osaka publicly claimed that gargle medicine containing the antiseptic povidone-iodine can fight coronavirus. Within days, these products all but disappeared from drugstore shelves in Japan. Then, gargle medication started to pop up on online third-party marketplace platforms, or "flea markets" as they are often called in Japan, where individuals can easily open an account and start selling anything they want - or so some thought.  But selling pharmaceuticals online, even over-the-counter drugs such as gargle medicine, can run afoul of Japanese regulations.

Third-party marketplaces, or online flea markets, are rife in Japan. The transaction volume of flea market apps alone, METI reported last year, amounted to about JPY640 billion in 2018 ($6.14 billion USD), showcasing a stark formation of a giant C2C market since its first appearance only six years before. But this open marketplace format has also become a breeding ground for illicit or otherwise problematic sales of various products. While platforms usually have written policies that prohibit sales of specific items, including pharmaceuticals, inappropriate listings keep popping up.

Resale of essential goods with a steep markup is one issue these platforms often face. LegitScript analysts observed price gouging for masks and hand sanitizers in the initial stage of the pandemic. It then also happened with toilet paper. Now, exorbitant pricing appears to be happening with gargle medicine. The addition problem with this particular item, though, is that gargle medicine containing povidone-iodine - which is the type the governor claimed was effective in combating the virus - is a Class III over-the-counter medicine, and it is illegal to sell such a product without a proper license, which most of these resellers do not have (see the Tokyo Metropolitan Government's warning).

Approved over-the-counter gargle medicine may seem tame, but it is just one of many violative and potentially dangerous pharmaceuticals being sold on these platforms. They include unapproved prescription drugs such as Kamagra (an unapproved erectile dysfunction drug), Finpecia (an unapproved hair loss treatment), and Careprost (an unapproved lash-thickening serum), as well as e-liquids that contain nicotine, which is considered an unapproved medicine in Japan. These platforms also frequently offer counterfeit products such as Louis Vuitton bags and Amiibo game cards; many merchants selling a sorts of fake goods on these platforms have been arrested. Illegal sales of products like these not only harms consumers but also puts the operators of marketplaces at risk as well as poses an elevated risk of BRAM and GBPP fines to payment service providers.

LegitScript's reach is global: our team comprises native speakers in more than 15 languages who monitor regulatory notices from over 100 countries and more than 175 government agencies. We monitor the internet for third-party marketplaces that may unwittingly or intentionally allow downstream sellers to offer illicit products, and we also provide services to platforms to monitor for improper listings. Contact us to learn more about our global monitoring solutions.

 

Recent Blog Articles

LegitScript Marketplace Risk Panel Recap: The Dark Side of Weight-Loss Drugs: Regulation, Risk, and Red Flags

Marketplaces and other online platforms must constantly revisit and stress test their policies to ensure they are properly mitigating risk while providing sufficient room for growth. But what happens when a new regulation or trend upends those policies? Listen below to an excerpt of the panel discus...

Trust, Risk, and the Future of Compliance: Key Takeaways from Marketplace Risk San Francisco 2025

Marketplace Risk San Francisco 2025 offered a rare opportunity to pause the noise and listen closely to the industry, to its undercurrents, and to the questions no one's asking on stage. Once you're tuned in, you begin to hear the real story: an acute urgency around platform trust, growing anxieties...

Partnering for Compliance: What Platforms and Pharmaceutical Manufacturers Need to Know

Pharmaceutical manufacturing is a quickly growing sector that in recent years has been riding a wave of demand resulting from the booming telehealth industry, GLP-1 weight loss drugs, and an aging population requiring increasing medical care. Keep reading to understand how pharmaceutical manufacturi...

What You Need to Know About KYB in Merchant Onboarding

If merchant onboarding is a security checkpoint into your merchant portfolio, then know your business (KYB) is the guard checking the IDs. In the payments world, KYB is all about verifying the legitimacy of a business and the people behind it before you let them onto your platform. Keep reading to u...